Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance

• DOI: 10.1002/alz.13891
• Publication Date: 2024-06-02T18:04:28Z
• Authors: Leanne Howard; Carla Abdelnour; Erin L. Abner; Ricardo F. Allegri; Hiroko H. Dodge; Serge Gauthier; Camilla M. Hoyos; Gregory A. Jicha; Patrick G. Kehoe; Catherine J. Mummery; Adesola Ogunniyi; Nikolaos Scarmeas; Xiaoying Chen; Jodie R. Titiner; Christopher R. Weber; ; Ruth Peters
• Keywords: Consensus conference

Recent growth in the functionality and use of technology has prompted an increased interest potential for remote or decentralized clinical trials dementia. There are many benefits associated with medication trials, but we currently lack specific recommendations their delivery dementia field.